Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Mature B-ALL and Burkitt Lymphoma (BL) in Adult Patients. BURKIMAB-14.

NCT05049473 is registered in ClinicalTrials.gov with PETHEMA Foundation as lead sponsor.

NCT NCT05049473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05049473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Mature B-ALL and Burkitt Lymphoma (BL) in Adult Patients. BURKIMAB-14.
Lead sponsor
PETHEMA Foundation
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2014
Completion date
January 31, 2024
Enrollment
100 (estimated)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

burkitt lymphoma (bl), mature b-cell leukemia burkitt type, unclassifiable lymphoma between dcbl and bl